Remilah, A. A., Krayim, B., Amir, E., Tibau, A., Robson, M. E., Abuhadra, N., Chen, Y., Shepshelovich, D., & Goldvaser, H. (2024). The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review. Critical Reviews in Oncology/Hematology, 202, 104455. https://doi.org/10.1016/j.critrevonc.2024.104455

Ferris, J. S., Morgan, D. A., Tseng, A. S., Terry, M. B., Ottman, R., Hur, C., Wright, J. D., & Genkinger, J. M. (2023). Risk factors for developing both primary breast and primary ovarian cancer: A systematic review. Critical Reviews in Oncology/Hematology, 190, 104081. https://doi.org/10.1016/j.critrevonc.2023.104081

Shabbir, A., Kojadinovic, A., Shafiq, T., & Mundi, P. S. (2023). Targeting RET alterations in cancer: Recent progress and future directions. Critical Reviews in Oncology/Hematology, 181, 103882. https://doi.org/10.1016/j.critrevonc.2022.103882